EARNEST PARTNERS LLC

Position in JNJ — Johnson & Johnson

CIK 1102578 ATLANTA, GA

Position in JNJ

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$217,062

+$23,621 QoQ

Shares Held

888

-28.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

16 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

EARNEST PARTNERS LLC holds $135,812,097 across 3 Drug Manufacturers - General names. JNJ ranks #3 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NVS	Novartis AG	885,290	$135,228,047
2	LLY	ELI LILLY & Co	399	$366,988
3	JNJ	Johnson & Johnson This page	888	$217,062

16 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$217,062	888	-28.5%	Shares	Sole	2026-05-15
2023-09-30	$193,441	1,242	0.0%	Shares	Sole	2023-11-14
2023-06-30	$205,575	1,242	0.0%	Shares	Sole	2023-08-07
2023-03-31	$192,510	1,242	0.0%	Shares	Sole	2023-05-15
2022-12-31	$219,399	1,242	0.0%	Shares	Sole	2023-02-14
2022-09-30	$202,893	1,242	0.0%	Shares	Sole	2022-11-14
2022-06-30	$220,467	1,242	0.0%	Shares	Sole	2022-08-12
2022-03-31	$220,119	1,242	0.0%	Shares	Sole	2022-05-16
2021-12-31	$212,468	1,242	0.0%	Shares	Sole	2022-02-07
2021-09-30	$200,583	1,242	0.0%	Shares	Sole	2021-11-15
2021-06-30	$204,607	1,242	0.0%	Shares	Sole	2021-08-16
2021-03-31	$204,122	1,242	0.0%	Shares	Sole	2021-05-17
2020-12-31	$195,465	1,242	0.0%	Shares	Sole	2021-02-16
2020-09-30	$184,908	1,242	-2.4%	Shares	Sole	2020-11-16
2020-06-30	$178,881	1,272	0.0%	Shares	Sole	2020-08-13
2020-03-31	$166,797	1,272	—	Shares	Sole	2020-05-14
No filing history on record for this holder in this stock.